Drug intelligence / Profile preview

albumin aggregated

Development stage
Approved
Lead developer
Jubilant DraxImage
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
Administration
Intravenous, Intraperitoneal
01

Overview

Albumin aggregated (Macroaggregated Albumin or MAA) is a sterile, non-pyrogenic preparation of aggregated human serum albumin used as a diagnostic radiopharmaceutical precursor. When radiolabeled with Technetium-99m (Tc-99m), it forms Technetium Tc 99m Albumin Aggregated Injection. The particles, typically ranging from 10 to 90 micrometers in size, are administered intravenously and become trapped in the pulmonary capillary bed through a process of temporary microembolization. This allows for lung scintigraphy to evaluate pulmonary perfusion, aiding in the diagnosis of pulmonary embolism and other perfusion defects. It is also used via intraperitoneal injection to assess the patency of peritoneovenous shunts in patients with portal-hypertensive ascites.

Brand names
DRAXIMAGE MAAPulmoliteMacrotecTechneScan MAA
Other names
Macroaggregated albuminTechnetium Tc 99m Albumin AggregatedHuman albumin microspheres

Beyond the preview

Go deeper on albumin aggregated.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albumin aggregated.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call